Source: APO
- Findings were presented at the 2026 Roche Africa Press Day in Nairobi (https://www.Roche.com), which convened journalists from nine African countries with policymakers and health experts
- The event focused on the theme “Health is Wealth,” exploring how investment in women’s health can drive economic growth and stronger health system
- Research reveals every dollar invested in innovative breast cancer treatments generates up to USD 12.40 in economic return
Investing strategically in the health of Africa’s women will unlock billions of dollars in economic growth, as well as saving lives and strengthening communities, according to speakers at Africa Press Day held in Nairobi on March 4-5.
Convened by healthcare company Roche, the 2026 edition of Africa Press Day gathered journalists from nine African countries, alongside policymakers, economists, health experts, and development finance leaders. They discussed evidence and case studies proving how public private partnerships and strategic investments in health systems, especially in women’s health, can build human capital, productive workforces, and resilient economies.
In a keynote address, Kenya’s Principal Secretary State Department for Medical Services, Ministry of Health, Dr Ouma Oluga, urged media to help shape an informed narrative about improving health: “When a health story is being told, what is most important to portray? Is it what is killing people? Is it the solutions that should stop what is killing people? Or is it the in-between—the administrative, resource, and policy actions that link the two?”
As African governments increasingly focus on economic diversification and productivity, speakers argued that health investment must be treated as core economic policy — not simply a social expenditure.
Health is Wealth: The Economic Case for Investment
To demonstrate the returns on investing in women’s health, Roche unveiled research (http://apo-opa.co/4b2mjzX) from the WifOR Institute showing how the aggressive form of HER2+ breast cancer (responsible for up to 20% of cases on the continent) caused over USD10 billion in lost productivity across seven African countries (Algeria, Côte d’Ivoire, Kenya, Morocco, Nigeria, South Africa, and Tunisia) from 2017-2023.
Nearly 90% of these losses came from women in their prime working years. The research also showed how every dollar invested in innovative cancer treatments can generate up to USD12.40 in economic returns, primarily by restoring women’s productivity and allowing for longer healthy working lives.
Maturin Tchoumi, Pharma International Area Head, Roche Africa, said: “Breast cancer is a rising threat to African societies and economies. The evidence clearly shows that investing in women’s health is not a cost or a social expense, but a powerful economic driver that underpins productivity, resilience, equity, and sustainable growth across the continent.”
Health Is Equity: Closing the Diagnosis Gap
Extending quality cancer care to all African women, regardless of geography or income, was a key theme of the event. This included closing the gaps in breast cancer screening and early diagnosis that lead to around 77 per cent (http://apo-opa.co/4cFcF7F) of African women being diagnosed in the later stages of the disease when it is much harder – and more expensive – to treat.
H.E. Dorothy Nyong’o, First Lady of Kisumu County, Chair of the Africa Cancer Foundation, and member of the Africa Breast Cancer Council, highlighted Kenya’s EMPOWER (http://apo-opa.co/4s7GuCH) initiative for breast and cervical cancer (which delegates visited at a local hospital). It has digitised the patient journey via 76 physical and virtual clinics, speeding up diagnosis and treatment. Since its founding in 2019, EMPOWER has reached over 235,000 women, enabling 3,225 to receive treatment, and been adopted by the National Cancer Institute of Kenya as a nationally integrated platform.
H.E. Dorothy Nyong’o said: “Tackling breast cancer is not just a moral issue; it’s a strategic choice. Kenya’s EMPOWER initiative highlights how partnership and digital innovation can create a step-change in women’s healthcare. It offers a blueprint to other African countries for public-private collaboration that drives systemic, equitable, and lasting change.”
Health is Resilience: Strengthening African Health systems
Throughout the 2026 Africa Press Day, speakers shared details of initiatives that are working to strengthen health systems, including:
- Women’s Integrated Care Services (WICs) in Kenya and Côte d’Ivoire, pilot projects that integrate women’s cancer services into primary health care for greater efficiency.
- Home grown pandemic preparedness efforts, including sustainable and integrated diagnostic facilities and laboratory networks.
- African-led science – including genomics and local research – that is contributing to African health sovereignty.
Distributed by APO Group on behalf of Roche.
For more information and interviews:
Najma Adan
Weber Shandwick
E: NAdan@webershandwick.com
T: +44 (0)7483 196 468
About Roche:
Founded in 1896 in Basel, Switzerland, as one of the first industrial manufacturers of branded medicines, Roche has grown into the world’s largest biotechnology company and the global leader in in-vitro diagnostics. The company pursues scientific excellence to discover and develop medicines and diagnostics for improving and saving the lives of people around the world. We are a pioneer in personalised healthcare and want to further transform how healthcare is delivered to have an even greater impact. To provide the best care for each person we partner with many stakeholders and combine our strengths in Diagnostics and Pharma with data insights from the clinical practice.
About Roche Africa:
Improving health is central to fulfilling the immense potential of the continent, yet millions of people continue to face obstacles to accessing the care they need, when they need it. To achieve our vision of a healthier future for all people in Africa, health systems must be able to manage the dual burden of communicable and non-communicable diseases (NCDs), and address the persistent, but solvable barriers to diagnosis, treatment and care. We know a one-size-fits-all approach won’t work for the unique challenges that each country in Africa faces, and that building the resilient and responsive systems we need will require everyone involved in health to work together.
